Molecular basis of asbestos-induced lung disease

Gang Liu1, Paul Cheresh, David W Kamp

  • 1Clinical Research Center, Affiliated Hospital of Guangdong Medical College, Zhangjiang, China. docgangliu@hotmail.com

Insights

Asbestos exposure causes lung diseases like asbestosis through complex molecular pathways involving oxidative stress and cell death. Understanding these mechanisms may lead to new treatments for asbestos-related illnesses and aging.

Area of Science:

  • Environmental Health
  • Molecular Biology
  • Pathology

Background:

  • Asbestos exposure is linked to asbestosis, lung cancer, and mesothelioma.
  • The precise molecular mechanisms driving asbestos-induced lung diseases remain incompletely understood.
  • Pathogenic pathways may vary based on asbestos fiber type, lung clearance rates, and host genetics.

Purpose of the Study:

  • To review key pathological changes following asbestos exposure.
  • To examine recently identified pathogenic pathways, particularly those involving oxidative stress.
  • To explore the molecular basis of asbestos-induced lung diseases for potential therapeutic targets.

Main Methods:

  • Review of existing literature on asbestos pathology and molecular mechanisms.
  • Focus on oxidative stress pathways, including reactive oxygen species (ROS) production.
  • Examination of mitochondrial DNA (mtDNA) damage and repair mechanisms, including the role of 8-oxoguanine DNA glycosylase (OGG1).

Main Results:

  • Alveolar epithelial cell apoptosis is an early event in asbestosis, regulated by mitochondria and p53.
  • The endoplasmic reticulum may modulate asbestos-induced apoptosis.
  • Interactions between ROS, mtDNA damage, p53, OGG1, and mitochondrial aconitase are crucial in disease pathogenesis.

Conclusions:

  • New insights into molecular pathways of asbestos-induced lung diseases are emerging.
  • Understanding these pathways could lead to novel therapeutic strategies.
  • Potential applications include treatments for degenerative diseases, tumors, and aging.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...